KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation
Pharmaceutical R&D veteran brings over 20 years of expertise in formulation development, ANDA filings, and regulated-market product innovation to strengthen MSN Laboratories’ global growth ambitions
First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe
The validation confirms the submission is complete, clearing the way for the EMA’s centralized review process to formally evaluate the therapy
Company may qualify for 180-day generic exclusivity as sole first applicant for Bayer’s Vitrakvi capsules in the U.S.
The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe
Consolidated entity plans to strengthen specialty pharmaceutical offerings, expand manufacturing capacity, and accelerate global market penetration across emerging regions
Pharma industry veteran brings extensive experience in commercial strategy, business growth, and market leadership to his expanded role at Cipla
Mohit Yadav reaffirmed government's commitment to improve competitiveness, enhance export capabilities and support the country's transition from volume-driven to value-driven exports
New Chesterbrook office strengthens customer engagement, partner collaboration, and regional expansion strategy
Subscribe To Our Newsletter & Stay Updated
